Deputy Dean from Perdana University, Malaysia

Sutha Devaraj is a dedicated researcher and academician with expertise in pharmaceutical sciences, specializing in drug discovery and pharmacology. She earned her Ph.D. in Pharmaceutical Sciences from Universiti Sains Malaysia (USM) in 2018, where her research focused on the development of optimized methods for preparing bioactive fractions of Strobilanthes crispus (L.) Bremek. Her work involved the quantification of the plant’s marker compound, contributing to advancements in natural product-based drug discovery. Before completing her Ph.D., Sutha obtained a Master’s in Pharmacology from USM in 2012. Her master’s thesis focused on the hepatoprotective properties of Curcuma xanthorrhiza Rox, exploring its potential for liver protection through its bioactive compounds. She also holds a B.Sc. (Hons) in Biotechnology from AIMST University, Malaysia, where she graduated with a CGPA of 3.41. This academic foundation in biotechnology provided her with a strong understanding of molecular biology and biochemistry, essential for her later research in pharmacology and drug development. Throughout her career, Sutha has contributed significantly to the study of plant-based compounds with medicinal properties, and her work has enhanced the understanding of their therapeutic potential. Her academic journey has been marked by a consistent focus on integrating practical research with innovative approaches in pharmaceutical sciences.

Professional Profile

Google Scholar

Education

Sutha Devaraj’s educational background is distinguished by her specialized studies in pharmaceutical sciences and pharmacology. She earned her Ph.D. in Pharmaceutical Sciences with a focus on Drug Discovery from Universiti Sains Malaysia (USM) in 2018. Her doctoral thesis, titled Development of an Optimized Method for the Preparation of Bioactive Fraction of Strobilanthes crispus (L.) Bremek and the Quantification of its Marker Compound, was instrumental in advancing research on bioactive compounds derived from natural sources. This work enhanced the understanding of the therapeutic potentials of Strobilanthes crispus, contributing to both pharmaceutical science and ethnomedicine. Before completing her Ph.D., Sutha obtained her Master of Science (M.Sc.) in Pharmacology from USM in 2012. Her research focused on the hepatoprotective and pharmacological properties of Curcuma xanthorrhiza Rox, and she published findings related to the effectiveness of its standardized ethanolic extract in protecting the liver, demonstrating her expertise in pharmacological testing and drug development. Sutha’s academic journey began with a Bachelor of Science (B.Sc.) in Biotechnology (Hons) from AIMST University in 2008, where she graduated with a CGPA of 3.41. This early foundation in biotechnology paved the way for her subsequent advanced studies in pharmacology and pharmaceutical sciences.

Professional Experience

Sutha Devaraj has accumulated significant experience in the field of pharmaceutical sciences and pharmacology. Throughout her career, she has worked with various academic and research institutions, where she has contributed to advancing the understanding of pharmacological mechanisms and drug discovery. As a researcher at Universiti Sains Malaysia (USM), Sutha has actively participated in projects focusing on the isolation and quantification of bioactive compounds from plants, which has led to important findings on their therapeutic potentials. She has collaborated with both local and international researchers to examine the pharmacological properties of natural products, a focus that has shaped her work in drug discovery. In addition to her research roles, Sutha has also contributed to teaching and mentoring undergraduate and postgraduate students. She has shared her expertise in pharmacology and biotechnology, helping shape the next generation of scientists. Through her work, Sutha has built a strong professional reputation, earning recognition for her in-depth understanding of drug development processes and her ability to implement novel methodologies in her research.

Research Skills

Sutha Devaraj possesses a wide array of research skills essential to her work in pharmaceutical sciences and pharmacology. Her proficiency in bioactive compound isolation and quantification has been demonstrated through her research on Strobilanthes crispus and Curcuma xanthorrhiza, both of which are significant to natural drug discovery. She is highly skilled in pharmacological testing, utilizing a range of in-vitro and in-vivo models to assess the therapeutic efficacy of plant-based extracts. In addition to her experimental capabilities, Sutha has expertise in analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry, which she has used to identify and quantify bioactive compounds in complex matrices. Her background in biotechnology provides her with a solid understanding of biochemical assays, including enzyme inhibition and receptor binding assays. Furthermore, Sutha has honed her skills in data analysis and interpretation, often using sophisticated statistical tools to evaluate research results. Her ability to combine these skills allows her to contribute to cutting-edge research in drug discovery, particularly in exploring new therapeutic agents derived from natural sources.

Research Interests

Sutha Devaraj’s research interests lie at the intersection of pharmacology, drug discovery, and natural products. She is particularly focused on the exploration of plant-based bioactive compounds and their potential applications in pharmaceutical development. Her Ph.D. research on Strobilanthes crispus exemplifies her dedication to the discovery of new therapeutic agents from natural resources. Sutha is passionate about investigating the hepatoprotective and anticancer properties of various plant species, particularly those indigenous to Southeast Asia. She is also interested in the mechanisms of action of these compounds, aiming to elucidate how they interact with biological systems to exert therapeutic effects. In addition to pharmacological studies, Sutha is keen on formulation development, specifically in optimizing methods for the preparation and stabilization of bioactive extracts. Her future research endeavors include furthering the development of natural-based drugs with fewer side effects compared to conventional synthetic drugs, contributing to a more sustainable and effective approach in pharmaceutical therapy.

Awards and Honors

Sutha Devaraj’s career has been marked by notable recognition for her academic and research contributions. She was awarded a PhD Fellowship by Universiti Sains Malaysia (USM), providing her with the opportunity to carry out high-impact research in the field of pharmaceutical sciences. Additionally, her M.Sc. research on Curcuma xanthorrhiza earned her accolades for its significance in hepatoprotective studies. Sutha’s ability to combine scientific rigor with practical applications has led to her work being published in well-respected, peer-reviewed journals. Her academic excellence and contributions to the field have earned her membership in several prestigious academic organizations and editorial positions in prominent journals related to pharmacology and drug development. Her work continues to be recognized by the academic community, highlighting her as an emerging leader in her field of expertise.

Conclusion

In conclusion, Sutha Devaraj is an accomplished researcher with a strong academic background and expertise in pharmacology and drug discovery. Her dedication to advancing natural product research has led to valuable contributions in the areas of bioactive compound isolation and pharmacological evaluation. Sutha’s research skills, which include advanced analytical techniques and experimental methodologies, equip her to make meaningful advances in the development of therapeutic agents. Her research interests reflect a deep commitment to exploring sustainable and effective natural-based drugs, particularly those with hepatoprotective and anticancer properties. With a growing reputation in the field, Sutha’s work continues to inspire innovation in the pharmaceutical sciences, and her achievements and contributions make her a prominent figure in the ongoing search for new, safer therapeutic options.

Publications Top Notes

1. Evaluation of the Antinociceptive Activity and Acute Oral Toxicity of Standardized Ethanolic Extract of the Rhizome of Curcuma xanthorrhiza Roxb

Authors: S. Devaraj, A.S. Esfahani, S. Ismail, S. Ramanathan, M.F. Yam
Journal: Molecules, 15(4), 2925–2934
Year: 2010
Citations: 97

2. Investigation of Antioxidant and Hepatoprotective Activity of Standardized Curcuma xanthorrhiza Rhizome in Carbon Tetrachloride‐Induced Hepatic Damaged Rats

Authors: S. Devaraj, S. Ismail, S. Ramanathan, M.F. Yam
Journal: The Scientific World Journal, 2014(1), 353128
Year: 2014
Citations: 75

3. Evaluation of the Hepatoprotective Activity of Standardized Ethanolic Extract of Curcuma xanthorrhiza Roxb

Authors: S. Devaraj, S. Ismail, S. Ramanathan, S. Marimuthu, Y.M. Fei
Journal: Journal of Medicinal Plants Research, 4(23), 2512–2517
Year: 2010
Citations: 53

4. Anti-Tumor Action, Clinical Biochemistry Profile and Phytochemical Constituents of a Pharmacologically Active Fraction of S. crispus in NMU-Induced Rat Model

Authors: N.S. Yaacob, H.M. Yankuzo, S. Devaraj, J.K.M. Wong, C.S. Lai
Journal: PLoS One, 10(5), e0126426
Year: 2015
Citations: 41

5. A Study on the Hepatoprotective Effect of Andrographis paniculata (Burm. F) Nees on Mice

Author: D. Sutha
Journal: Journal of Phytology, 2(11)
Year: 2010
Citations: 35

6. In Vivo Toxicological Investigations of Standardized Ethanolic Extract of Curcuma xanthorrhiza Roxb. Rhizome

Authors: S. Devaraj, S. Ismail, S. Ramanathan, M. FeiYam
Journal: Journal of Natural Products and Plant Resources, 3(1), 67–73
Year: 2013
Citations: 28

7. Explorations of CRISPR/Cas9 for Improving the Long-Term Efficacy of Universal CAR-T Cells in Tumor Immunotherapy

Authors: M. Naeem, A. Hazafa, N. Bano, R. Ali, M. Farooq, S.I. Abd Razak, T.Y. Lee, et al.
Journal: Life Sciences, 316, 121409
Year: 2023
Citations: 23

8. Phytochemical, Antioxidant, Antipyretic and Anti-inflammatory Activities of Aqueous-Methanolic Leaf Extract of Mangifera indica

Authors: Q.U. Ain, M.O. Iqbal, I.A. Khan, N. Bano, M. Naeem, M.I. Jamaludin, S. Devaraj
Journal: American Journal of Translational Research, 15(7), 4533
Year: 2023
Citations: 15

9. Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients

Authors: M. Naeem, N. Bano, S. Manzoor, A. Ahmad, N. Munawar, S.I.A. Razak, T.Y. Lee, et al.
Journal: Biomolecules, 13(1), 99
Year: 2023
Citations: 10

10. Innovative Aspects and Applications of Single Cell Technology for Different Diseases

Authors: A. Ali, S. Manzoor, T. Ali, M. Asim, G. Muhammad, A. Ahmad, M.I. Jamaludin, et al.
Journal: American Journal of Cancer Research, 14(8), 4028
Year: 2024
Citations: 1

11. Understanding the Role of Pharmacology and Toxicology in the Research, Development, and Innovation Process by Analyzing the Drug Development Process

Authors: L. Waheed, I. Ur Rehman, S. Devaraj, F.H.G.Q. Al-Amier, P. Jativa, G. Naz, et al.
Journal: Journal of Pharmaceutical Negative Results, Vol. 14
Year: 2023
Citations: 1

Rohidas Arote | Pharmaceutical Science | Biotechnology Advancement Award

Posted on 15/03/202515/03/2025 by Shen Awards

Prof. Rohidas Arote | Pharmaceutical Science | Biotechnology Advancement Award

Dr. Rohidas B. Arote is a distinguished professor in the Center for Nano and Material Sciences at Jain University, Bangalore, India. With over two decades of experience in biotechnology, gene therapy, and drug delivery, he has made substantial contributions to biomedical research. His expertise lies in biomaterials, pharmacology, toxicology, and theranostics, particularly in cancer, immune, and regenerative therapies. Having served as a professor at Seoul National University (SNU), a globally ranked institution, he has led groundbreaking research in non-viral gene delivery systems and targeted drug delivery for cancer therapy. Dr. Arote has secured major research grants, collaborated with international institutions, and delivered invited talks at global conferences. He has received prestigious awards such as the Creative Pioneering Research Award and IAAM Scientist Medal. In addition to his academic achievements, he actively contributes to international scientific societies, reviews for high-impact journals, and organizes leading scientific conferences. With a strong track record of publications, research funding, and innovation, Dr. Arote continues to be a key figure in biomedical and pharmaceutical sciences, advancing cutting-edge solutions for healthcare and drug development.

Professional Profile

Scopus Profile

Education

Dr. Rohidas B. Arote holds a Ph.D. in Biotechnology (2009) from Seoul National University, South Korea, where he specialized in gene therapy and drug delivery systems. His doctoral research focused on developing non-viral polymeric gene carriers for targeted cancer therapy. Before pursuing his Ph.D., he earned a Master of Science (M.S.) in Pharmacognosy and Phytochemistry (2002) from the University of Mumbai, India, where he gained expertise in natural product chemistry and pharmaceutical formulations. His academic journey began with a Bachelor of Science (B.S.) in Pharmaceutical Sciences (2000) from the University of Pune, India, equipping him with a strong foundation in pharmaceutics, drug formulation, and biotechnology. Throughout his education, he has been a recipient of several prestigious fellowships, including the Brain Korea (BK21) Fellowship (2008) and the Korea Science and Engineering Fellowship (KOSEF) (2005). He was also a GATE Scholar in Pharmacy (2000), a competitive national-level qualification exam conducted by IIT Kharagpur, India. His interdisciplinary academic background, spanning biotechnology, pharmaceutical sciences, and biomedical engineering, has enabled him to develop innovative solutions in gene therapy, biomaterials, and targeted drug delivery.

Professional Experience

Dr. Rohidas B. Arote has over 20 years of academic and research experience across prestigious institutions worldwide. He is currently a Professor at the Center for Nano and Material Sciences, Jain University, Bangalore (2021-present), where he leads cutting-edge research in nanomedicine and biomaterials. Prior to this, he served at Seoul National University (SNU), South Korea, as an Associate Professor (2017-2020) and Assistant Professor (2010-2017), where he developed gene delivery technologies for cancer therapy. He also worked as a Research Associate (2009-2010) at SNU, focusing on polymeric carriers for gene therapy. In addition, he held visiting professor positions at King Abdullah University of Science and Technology (KAUST), Saudi Arabia (2019-2020), and the Indian Institute of Science (IISc), Bangalore (2019-2020), contributing to advanced biomedical research. Early in his career, he gained industry experience as a Formulation & Development Scientist at Ajanta Pharma Ltd, Mumbai (2003-2004). His diverse academic, research, and industry experience has made him a leader in drug delivery, biomaterials, and biomedical engineering.

Research Interests

Dr. Rohidas B. Arote’s research focuses on gene therapy, drug delivery, biomaterials, biomedical engineering, pharmacology, toxicology, and theranostics. He is particularly interested in developing novel non-viral gene delivery systems for targeted cancer therapy. His work involves designing biodegradable polymeric nanocarriers for effective gene transfection, with applications in cancer, immune, and regenerative therapies. He explores nanotechnology-based drug delivery to enhance the bioavailability and therapeutic efficacy of pharmaceuticals. Additionally, he investigates biocompatible materials for tissue engineering and regenerative medicine, contributing to the development of next-generation biomaterials for medical applications. His interdisciplinary research bridges biotechnology, materials science, and pharmaceutical sciences, addressing critical challenges in disease treatment and drug delivery. Through collaborations with global research institutions, he continues to push the boundaries of biomedical research by integrating nanomedicine, molecular biology, and bioengineering to develop innovative therapeutic strategies.

Research Skills

Dr. Rohidas B. Arote possesses a diverse set of advanced research skills in biomedical and pharmaceutical sciences. He is an expert in nanotechnology-based drug delivery, specializing in the synthesis and characterization of biodegradable polymers for gene therapy applications. He has expertise in molecular biology techniques, including gene cloning, siRNA delivery, and CRISPR-based genome editing. His skills extend to polymeric biomaterials design, nanoparticle synthesis, and surface modification for targeted drug delivery. He is proficient in in vitro and in vivo models for evaluating gene expression, drug efficacy, and toxicity in preclinical studies. Additionally, he has experience in high-throughput screening, bioinformatics, and computational modeling for drug formulation optimization. His research involves the development of multifunctional polymeric carriers, receptor-mediated drug targeting, and biodegradable materials for regenerative medicine. His strong analytical and problem-solving abilities have enabled him to successfully secure research funding, publish in top-tier scientific journals, and contribute to cutting-edge biomedical innovations.

Awards and Honors

Dr. Rohidas B. Arote has received numerous prestigious awards for his pioneering research in gene therapy and biomaterials. He was honored with the Creative Pioneering Research Award (2017) from Seoul National University, recognizing his innovative contributions to biomedical research. He also received the IAAM Scientist Medal (2017) from the International Association of Advanced Materials, highlighting his excellence in advanced materials and nanomedicine. Other notable accolades include the Research Excellence Award (2010) from the Research Institute for Agriculture and Life Sciences and the Young Scientist Award (2008) from the 16th POLYCHAR: World Forum on Advanced Materials. He has been a Brain Korea (BK21) Fellow (2008) and received the Korea Science and Engineering Fellowship (KOSEF) (2005). His early academic achievements include being a GATE Scholar in Pharmacy (2000), a highly competitive national-level distinction. These awards reflect his outstanding research contributions, leadership in academia, and dedication to advancing biomedical sciences.

Conclusion

Dr. Rohidas B. Arote is an exceptional researcher and academic leader with a remarkable career spanning over two decades in biotechnology, gene therapy, and drug delivery. His contributions in biomaterials, nanomedicine, and regenerative therapies have significantly advanced the field of biomedical sciences. Through his research, funding acquisitions, and scientific collaborations, he has played a crucial role in developing novel drug delivery systems for cancer therapy. His achievements in securing high-impact publications, international awards, and research grants showcase his dedication to scientific excellence. In addition to his research, he has contributed as a peer reviewer, conference organizer, and mentor, shaping the next generation of biomedical researchers. As a professor at Jain University, Bangalore, and a former faculty member at Seoul National University, he continues to lead groundbreaking research in nanomedicine. With his strong academic background, innovative research, and global scientific impact, Dr. Arote stands as a deserving candidate for prestigious research awards, making a lasting impact in healthcare and pharmaceutical sciences.

Publications Top Notes

Title: Microfluidics in Bioanalytical Chemistry
Authors: R. Nisarga, P.P. Pandit, J.N. Sangshetti, R.B. Arote
Year: Not provided
Title: Exploring Antibiofilm Potential of Some New Imidazole Analogs Against C. Albicans: Synthesis, Antifungal Activity, Molecular Docking and Molecular Dynamics Studies
Authors: S.K. Pathan, A.V. Shelar, S.U. Deshmukh, R.H. Patil, J.N. Sangshetti
Year: 2023
Citations: 1
Title: In Silico Structure-Based Drug Design Approach to Find Potential Hits in Ventilator-Associated Pneumonia Caused by Pseudomonas aeruginosa
Authors: M.G. Damale, R.B. Patil, S.A. Ansari, R.B. Arote, J.N. Sangshetti
Year: 2022
Citations: 2
Title: Efficient Gene Transfection to Lung Cancer Cells via Folate-PEI-Sorbitol Gene Transporter
Authors: K. Cho, S. Kim, H. Chun, A. Lee, R.B. Arote
Year: 2022
Citations: 6
Title: Development of Novel, Biocompatible, Polyester Amines for Microglia-Targeting Gene Delivery
Authors: B. Choi, M. Ahn, S. Hong, R.B. Arote, S.J. Lee
Year: 2021
Citations: 1
Title: Insights of Tankyrases: A Novel Target for Drug Discovery
Authors: M.G. Damale, S.K. Pathan, D.B. Shinde, R.B. Arote, J.N. Sangshetti
Year: 2020
Citations: 26
Title: Boric Acid: A Versatile Catalyst in Organic Synthesis
Authors: S.K. Pathan, P.R. Mahaparale, S.U. Deshmukh, R.B. Arote, J.N. Sangshetti
Year: Not provided
Citations: 5

Khushi Quadri | Pharmacology | Best Researcher Award

Posted on 22/11/202422/11/2024 by Shen Awards

Ms. Khushi Quadri | Pharmacology | Best Researcher Award

Research Scholar at SGT COLLEGE OF PHARMACY, India

Khushi Quadri is a passionate and driven researcher in the field of pharmaceutics, with a strong focus on nanotechnology, drug delivery systems, and biomedical applications. She has excelled academically, achieving an impressive 88.6% in her Master’s program at SGT University, Gurugram. Khushi has contributed extensively to the scientific community through publications in reputed journals such as Elsevier and iLiver. Her research spans diverse areas, including neurological disease treatments, biosensors, and eco-friendly nanomaterials. She has presented her work at several national and international conferences, showcasing her ability to effectively communicate complex scientific ideas. Khushi’s dedication to innovation and excellence has earned her recognition in competitions and tech fests. Alongside her academic and research pursuits, she has developed skills in teamwork, communication, and adaptability, making her a well-rounded professional.

Professional Profile

Education

Khushi Quadri has a robust academic foundation in pharmacy and pharmaceutics. She is currently completing her Master’s degree in Pharmaceutics at SGT University, Gurugram (2022-2024), where she has maintained an exceptional 88.6% score. Prior to this, she earned her Bachelor’s degree in Pharmacy from B.S. Anangpuria Institute of Pharmacy, Faridabad, achieving 75.7%. Her earlier education includes a solid performance in Class XII and Class X from Kalka Public School, Alaknanda, with scores of 86.8% and 76%, respectively. This strong educational background reflects her consistency and commitment to academic excellence.

Professional Experience

Khushi has actively engaged in professional academic and research activities. Her experience includes presenting posters at multiple international and national conferences, focusing on innovative topics like eco-friendly nanoparticles, biosensors, and drug delivery systems. She has also participated in numerous workshops, gaining hands-on knowledge in areas like tablet compression, coating techniques, and spectroscopy. Through these engagements, she has honed her research and presentation skills, enabling her to effectively contribute to the scientific community.

Research Interests

Khushi’s research interests lie at the intersection of pharmaceutics, nanotechnology, and biomedical sciences. She is particularly focused on green synthesis of nanoparticles for drug delivery and therapeutic applications, including neurological diseases and cancer treatment. Her work also explores the role of inorganic nanoparticles in water purification, biosensors, and antimicrobial therapies. Her commitment to sustainable research is evident in her studies on eco-friendly materials and their environmental impact.

Research Skills

Khushi Quadri possesses a diverse skill set that complements her research activities. She is proficient in designing and optimizing green synthesis techniques for nanoparticles and evaluating their biomedical applications. Her expertise extends to spectroscopic techniques, including FTIR and UV spectroscopy, and she has a strong grasp of Microsoft Excel and Word for data analysis and documentation. Additionally, her collaborative and adaptable nature allows her to effectively work in multidisciplinary teams, contributing innovative solutions to complex research challenges.

Awards and Honors

Khushi has been recognized for her academic and research excellence through several awards and honors. Notably, she secured 3rd rank in the Synergy Tech Fest 2023 for her project on eco-friendly mosquito repellents. She has also participated in various competitive events, including national conferences and debates, reflecting her proactive engagement with the academic community. Certificates of appreciation for her achievements in CBSE board exams and employability skills further underscore her dedication to personal and professional growth.

Conclusion 🎯

Khushi Quadri has demonstrated commendable achievements in academic performance, research, and conference participation, making her a strong candidate for early-career researcher recognition. However, for a Best Researcher Award, areas like deep specialization, innovation, international collaboration, and leadership experience may need further development.

Publication Top Notes

New Approaches to the Treatment of Metabolic Dysfunction-Associated Steatotic Liver with Natural Products
- Authors: P. Yadav, K. Quadri, R. Kadian, A. Waziri, P. Agrawal, M.S. Alam
- Journal/Source: iLIVER
- Year: 2024
- Citation: P. Yadav, K. Quadri, R. Kadian, A. Waziri, P. Agrawal, M.S. Alam, “New Approaches to the Treatment of Metabolic Dysfunction-Associated Steatotic Liver with Natural Products,” iLIVER, vol. 100131, 2024.
A New Era of Nanotechnology Applied in Neurological Disease Treatment
- Authors: A.S.M.S.A. Jayamanti Pandit, Charu Bharti, Surbhi Gupta, Syed Muzammil Munawar
- Book/Source: Essential Guide to Neurodegenerative Disorders: Mechanistic, Diagnostic and Therapeutic Insights
- Year: 2024
- Citation: A.S.M.S.A. Jayamanti Pandit, Charu Bharti, Surbhi Gupta, Syed Muzammil Munawar, “A New Era of Nanotechnology Applied in Neurological Disease Treatment,” in Essential Guide to Neurodegenerative Disorders: Mechanistic, Diagnostic and Therapeutic Insights, 2024.
Potential Role of Probiotics in Neurological Disease Treatment
- Authors: M.S.A. Khushi Quadri, Sagar Thakur, Sushma Chaturvedi, Renu Kadian, Geeta Rawat
- Book/Source: Essential Guide to Neurodegenerative Disorders: Mechanistic, Diagnostic and Therapeutic Insights
- Year: 2024
- Citation: M.S.A. Khushi Quadri, Sagar Thakur, Sushma Chaturvedi, Renu Kadian, Geeta Rawat, “Potential Role of Probiotics in Neurological Disease Treatment,” in Essential Guide to Neurodegenerative Disorders: Mechanistic, Diagnostic and Therapeutic Insights, 2024.

Seval Bulut | Pharmacology | Best Researcher Award

Posted on 12/11/202412/11/2024 by Shen Awards

Assist. Prof. Dr. Seval Bulut | Pharmacology | Best Researcher Award

Erzincan Binali Yıldırım University at Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yıldırım University, Turkey

Dr. Seval Bulut is an accomplished researcher and Assistant Professor in the Department of Pharmacology at Erzincan Binali Yıldırım University in Turkey. With an extensive background in medicine and pharmacology, her research focuses on drug safety, therapeutic interventions, and protective effects of natural extracts on organ function. Dr. Bulut’s prolific work includes 45 research articles published in leading SSCI and SCIE journals, where she has explored biochemical and histopathological mechanisms underlying drug-induced toxicity and protective pharmacological agents. Her studies span organ systems and conditions such as hepatotoxicity, renal damage, reproductive health, and ischemic syndrome, showcasing a robust interdisciplinary approach. Dr. Bulut has contributed to advancing pharmacological research with her findings on natural compounds and coenzyme Q10’s efficacy in mitigating organ dysfunction. Her academic influence extends through her roles as a physician and educator, mentoring emerging researchers in pharmacology. Dr. Bulut’s dedication to drug safety and therapeutic research has not only bolstered her professional reputation but also holds promise for improving patient care and drug efficacy in clinical settings.

Professional Profile

Scopus Profile

Education

Dr. Seval Bulut’s educational background exemplifies her dedication to the fields of medicine and pharmacology. She earned her MD from Atatürk University Faculty of Medicine in 2001, embarking on her journey as a physician committed to improving patient outcomes. Dr. Bulut later transitioned to academia, pursuing a doctoral program at Erzincan Binali Yıldırım University’s Institute of Health Sciences, Department of Medical Pharmacology. In 2024, she completed her PhD with a thesis titled “The Effect of Liv-52 on Favipiravir-Induced Hepatotoxicity in Rats: Biochemical and Histopathological Evaluation,” demonstrating her keen focus on pharmacology, particularly in drug-induced toxicity. This advanced education has equipped Dr. Bulut with a strong foundation in both clinical and research aspects of pharmacology, enabling her to investigate the biochemical mechanisms of drug interactions and develop therapeutic strategies for organ protection. Her academic journey reflects a consistent focus on integrating medical practice with pharmacological research to address real-world health challenges.

Professional Experience

Dr. Bulut’s professional experience is rooted in her dual roles as a clinician and researcher. She initially practiced medicine across various health institutions from 2001 to 2010, gaining valuable hands-on experience that provided her with a comprehensive understanding of patient care. Transitioning to a Family Physician role between 2010 and 2024, she developed a strong patient-focused perspective, which later became integral to her research approach. Currently, Dr. Bulut serves as an Assistant Professor in the Department of Pharmacology at Erzincan Binali Yıldırım University. In this academic role, she has combined her clinical insights with research expertise, conducting studies on pharmacological interventions to protect against drug-induced organ damage. Her extensive background in clinical medicine complements her current research endeavors, where she investigates the biochemical and histopathological mechanisms of pharmacological agents. This blend of professional experience positions Dr. Bulut as a knowledgeable researcher who brings both theoretical and practical insights to her field.

Research Interests

Dr. Seval Bulut’s research interests lie at the intersection of pharmacology, toxicology, and therapeutic interventions. She is particularly focused on understanding drug-induced toxicity and the protective effects of natural compounds on organ systems. Her work has centered on evaluating the biochemical and histopathological mechanisms of various pharmacological agents, including the impact of drugs such as favipiravir on liver health. Dr. Bulut’s studies also explore natural compounds like coenzyme Q10 and cinnamon extract for their potential to mitigate organ dysfunction, particularly in kidney and liver applications. Additionally, she has examined the effects of pharmaceutical compounds on reproductive health, as well as protective pharmacological strategies for conditions such as ischemic ocular syndrome. Her research contributes to improving drug safety and efficacy, providing insights that could lead to safer clinical applications and therapeutic innovations. Through her interdisciplinary research, Dr. Bulut aims to enhance the understanding of pharmacodynamics and pharmacokinetics in therapeutic contexts.

Research Skills

Dr. Seval Bulut has developed a broad set of research skills essential to her pharmacological studies. She is adept in designing and conducting in vivo experiments, specifically using animal models to assess drug efficacy and toxicity. Her skills in biochemical and histopathological analysis are evidenced in her research on drug-induced organ toxicity, where she utilizes various biochemical markers and staining techniques to evaluate cellular and tissue changes. Dr. Bulut is also proficient in data analysis and interpretation, crucial for her work in pharmacology and toxicology, where she frequently analyzes complex datasets to draw meaningful conclusions about drug interactions and therapeutic effects. Additionally, she is skilled in the ethical and methodological aspects of animal research, ensuring that her studies meet rigorous scientific standards. Her collaborative skills are reflected in her ability to work alongside other professionals, contributing to a multidisciplinary approach in her studies on pharmacological agents and natural compounds.

Awards and Honors

Dr. Seval Bulut’s academic and professional achievements have earned her recognition in the scientific community. Her prolific publication record includes 45 research articles indexed in SSCI and SCIE, which demonstrates her commitment to advancing pharmacological research. These publications span influential journals, highlighting her research’s impact and relevance in the field. Dr. Bulut’s focus on drug safety, natural therapeutics, and organ protection has led to invitations to present her findings at international congresses, further establishing her as a respected voice in pharmacology. Additionally, her progression from a practicing physician to a PhD-holder and Assistant Professor in a highly specialized research area reflects her dedication to both medical practice and academia. Although specific awards are not listed, her consistent scholarly contributions and active research agenda signal her as a promising candidate for future awards recognizing excellence in research and contributions to pharmacology. Her work holds significant implications for clinical safety and therapeutic advancements, which are critical areas of modern medical research.

Conclusion

Dr. Seval Bulut is a strong candidate for the Best Researcher Award due to her significant contributions to pharmacological research and her commitment to addressing drug safety and therapeutic efficacy. Her expertise, publication volume, and applied research focus on organ protection and biochemical evaluation highlight her as an impactful researcher. Continued emphasis on international collaboration, active conference participation, and funding pursuit could further elevate her profile and ensure sustained research advancements.

Publications Top Notes

Title: Effect of ethyl acetate extract from Usnea longissima on chemotherapy-associated multiple organ dysfunction in rats
Authors: Bingul, E., Bulut, S., Mammadov, R., Suleyman, H., Mendil, A.S.
Journal: Biomedicine and Pharmacotherapy
Year: 2024
Volume: 181
Article ID: 117636
Title: The hormonal mechanism of the effects of meperidine, sertraline, tianeptine, and their combinations on reproductive functions in female rats
Authors: Yilmaz, B.K., Suleyman, Z., Suleyman, B., Coban, T.A., Suleyman, H.
Journal: Biomedicine and Pharmacotherapy
Year: 2024
Volume: 178
Article ID: 117160
Title: Lacidipine, thiamine pyrophosphate and their combination on the ocular ischemic syndrome induced by bilateral common carotid artery ligation
Authors: Cicek, I., Somuncu, A.M., Altuner, D., Tastan, T.B., Suleyman, H.
Journal: International Journal of Ophthalmology
Year: 2024
Volume: 17, Issue 5
Pages: 815–821
Title: Effects of adenosine triphosphate, Lacidipine, and Benidipine on 5-fluorouracil-induced kidney damage in rats
Authors: Dagel, T., Altuner, D., Suleyman, B., Gulaboglu, M., Suleyman, H.
Journal: European Review for Medical and Pharmacological Sciences
Year: 2024
Volume: 28, Issue 6
Pages: 2538–2549
Title: Comparative study of the protective effects of coenzyme Q10 and cinnamon extract on possible kidney damage and dysfunction of amiodarone in rats
Authors: Ekici, O., Gul, A., Keskin, E., Gunay, M., Suleyman, H.
Journal: Clinical and Experimental Nephrology
Year: 2024
Title: Protective effects of thiamine pyrophosphate and cinnamon against oxidative liver damage induced by an isoniazid and rifampicin combination in rats
Authors: Yeter, B., Mammadov, R., Koc, Z., Gulaboglu, M., Suleyman, H.
Journal: Investigacion Clinica (Venezuela)
Year: 2024
Volume: 65, Issue 3
Pages: 321–334
Title: Protective effect of cinnamon extract against cobalt-induced multiple organ damage in rats
Authors: Isik, B., Suleyman, B., Mammadov, R., Coban, T.A., Suleyman, H.
Journal: Frontiers in Pharmacology
Year: 2024
Volume: 15
Article ID: 1384181
Title: Role of L-, N- and T-type calcium channels in achieving maximum analgesic and minimum toxic effect of tramadol
Authors: Yilmaz, M., Suleyman, B., Mammadov, R., Coskun, R., Suleyman, H.
Journal: Acta Poloniae Pharmaceutica – Drug Research
Year: 2024
Volume: 81, Issue 1
Pages: 135–143
Title: Protective Effect of Ramipril Against Oxidant and Proinflammatory Cytokine Damage Induced by Ischemia-Reperfusion in Ovarian Tissue in Rats
Authors: Ulug, P., Nayki, U., Mammadov, R., Coban, T.A., Suleyman, H.
Journal: Transplantation Proceedings
Year: 2024
Volume: 56, Issue 1
Pages: 215–222
Title: Effect of pycnogenol on ischemia/reperfusion-induced oxidative and inflammatory damage in the ovaries of rats
Authors: Dinc, K., Kiremitli, S., Suleyman, B., Altuner, D., Suleyman, H.
Journal: Tropical Journal of Pharmaceutical Research
Year: 2023
Volume: 22, Issue 11
Pages: 2297–2303

Prem Shankar Mishra | Pharmaceutical Science | Best Researcher Award

Posted on 14/10/202415/10/2024 by Shen Awards

Dr. Prem Shankar Mishra | Pharmaceutical Science | Best Researcher Award

Professor at Galgotias University, India

Dr. Sheryene Tejeda is a distinguished medical scientist based in Palm Beach Gardens, Florida, with a profound commitment to advancing healthcare through research and integrative therapies. With over 15 years of extensive experience in clinical and scientific environments, she has established herself as a leader in medical research and protocol development. Dr. Tejeda’s diverse background spans multiple domains, including oncology, neurology, and behavioral health, where she has significantly contributed to the understanding and treatment of complex medical conditions. Her passion for bridging scientific discovery and clinical practice drives her innovative approaches to improving patient care and health outcomes.

Professional Profile

Education

Dr. Tejeda holds an impressive educational background, starting with a Bachelor’s degree in Communications and Psychology, which laid the foundation for her understanding of human behavior and communication in healthcare. She furthered her education with a Master’s in Forensic Science, enhancing her analytical skills in evidence evaluation and research methodologies. Dr. Tejeda then obtained a Master’s in Health Science, focusing on the integration of scientific knowledge into practical health solutions. Most notably, she earned her PhD in Biomedical Science from Einstein Medical School, where her research emphasized the intersection of molecular biology and clinical applications. This robust educational foundation has empowered her to navigate complex scientific inquiries and contribute meaningfully to her field.

Professional Experience

Throughout her career, Dr. Tejeda has held various pivotal roles that highlight her expertise and leadership in the medical field. As a Lead Medical Scientist at Medicinal Technologies, she spearheaded projects aimed at developing innovative therapeutic protocols, collaborating with multidisciplinary teams to ensure the efficacy and safety of new treatments. Additionally, her work as a Contract Co-occurring Consultant allowed her to address the complexities of patients with concurrent medical and behavioral health issues. As a Clinical Research Associate, she has managed numerous clinical trials, ensuring compliance with regulatory standards while advocating for patient safety. Dr. Tejeda’s professional experience reflects her commitment to advancing medical knowledge and improving healthcare delivery through research and collaboration.

Research Interests

Dr. Tejeda’s research interests are deeply rooted in the pursuit of integrative therapies and their applications in clinical settings. She is particularly focused on the intersection of oncology and neurology, exploring how innovative treatment modalities can enhance patient outcomes and quality of life. Her work encompasses the investigation of co-occurring medical conditions and their impact on treatment efficacy, emphasizing the need for comprehensive care approaches. Dr. Tejeda is also dedicated to the development of evidence-based protocols that bridge the gap between scientific research and clinical practice, advocating for the incorporation of holistic methodologies in patient management. Her research endeavors are driven by a desire to contribute to the advancement of personalized medicine and improve the overall healthcare landscape.

Awards and Honors

Throughout her illustrious career, Dr. Sheryene Tejeda has been recognized for her outstanding contributions to the medical research community. She has received several prestigious awards for her innovative research and dedication to patient care, underscoring her impact in the field. Among her accolades, Dr. Tejeda was honored with the Excellence in Research Award at Einstein Medical School for her groundbreaking doctoral dissertation, which has been cited widely in subsequent studies. Additionally, her leadership in clinical trials has garnered recognition from multiple healthcare organizations, further solidifying her reputation as a leading expert in her field. Dr. Tejeda’s commitment to excellence and her relentless pursuit of knowledge continue to inspire her colleagues and students alike.

Conclusion

Dr. Prem Shankar Mishra is a strong candidate for the Best Researcher Award, given his impressive academic credentials, substantial research contributions, effective leadership, and commitment to advancing pharmaceutical sciences. By addressing the suggested areas for improvement, he can further elevate his research profile and enhance his contributions to the field. His dedication to mentoring the next generation of researchers and fostering collaboration positions him as a valuable asset to the academic and scientific community.

Publication top noted

📖 Novel 2-pyridone Analogs with Anti-cancer Activity: Synthesis, In silico, and In vitro Evaluation
🗓 Year: 2024
🔗 DOI: 10.2174/1570180820666230223113234
📝 Contributors: Prem Shankar Mishra, Velayutham Ravichandiran, Rakhi Mishra
📖 Comprehensive Review on Alzheimer’s Disease: Natural Therapeutics, Gaps and Challenges
🗓 Year: 2024
🔗 DOI: 10.2174/0118715249307525240614073143
📝 Contributors: Prem Shankar Mishra, Rakhi Mishra, Anuj Kumar
📖 Role of Natural Secondary Metabolites as HIF-1 Inhibitors in Cancer Therapy
🗓 Year: 2024
🔗 DOI: 10.1007/s00044-024-03219-x
📝 Contributors: Prem Shankar Mishra, Rakhi Mishra, Vaishali Manikrao Patil, Samiksha Dewangan
📖 A Comprehensive Study on Synthesis and Biological Activities of Pyridazine Derivatives
🗓 Year: 2021
🔗 DOI: 10.52711/0974-360X.2021.00595
📝 Contributors: Malik, A.; Mishra, R.; Mazumder, R.; Mazumder, A.; Mishra, P.S.
📖 Computational Docking Technique for Drug Discovery: A Review
🗓 Year: 2021
🔗 DOI: 10.52711/0974-360X.2021.00968
📝 Contributors: Mishra, R.; Mishra, P.S.; Mazumder, R.; Mazumder, A.; Chaudhary, A.
📖 Therapeutic Potential of Herbal Molecules Against Breast Cancer
🗓 Year: 2021
🔗 DOI: 10.2174/1573401317666210111110556
📝 Contributors: Prem Shankar Mishra
📖 Efficient Green Synthesis and Biological Evaluation of Thiadiazole Derivatives
🗓 Year: 2021
🔗 DOI: 10.33263/lianbs103.25942604
📝 Contributors: Prem Shankar Mishra
📖 Design, Synthesis, and Characterization of 2-Pyridone Derivatives as c-Jun N-Terminal Kinases (JNKs) Signaling Pathway Inhibitors
🗓 Year: 2017
🔗 DOI: 10.5958/0974-360X.2017.00684.9
📝 Contributors: Mishra, P.S.; Vijey Aanandhi, M.; Ravichandiran, V.
📖 Synthesis, Characterization and Antitumor Potential of Cinnamoyl Urea Derivatives
🗓 Year: 2016
🔗 DOI: 10.14233/ajchem.2016.19403
📝 Contributors: Chaudhary, R.; Shuaib, M.; Hashim, S.R.; Mishra, P.S.
📖 Synthesis, Characterization and Free Radical Scavenging Activity of 2-Azetidinone Derivatives
🗓 Year: 2015
🔗 DOI: Not available
📝 Contributors: Mishra, P.S.; Himanshu; Gupta, S.K.; Mishra, R.
📖 Synthesis, Characterization and Tubulin-Interaction Profile of Substituted Cinnamoyl Urea Derivatives
🗓 Year: 2015
🔗 DOI: Not available
📝 Contributors: Chaudhary, R.; Shuaib; Riaz Hashim, S.; Mishra, P.S.
📖 A Review on the Vanillin Derivatives Showing Various Biological Activities
🗓 Year: 2012
🔗 DOI: Not available
📝 Contributors: Kumar, R.; Sharma, P.K.; Mishra, P.S.
📖 A Review on Herbal Antidiabetic Drugs
🗓 Year: 2011
🔗 DOI: Not available
📝 Contributors: Mishra, R.; Shuaib, M.; Shravan; Mishra, P.S.
📖 Synthesis, Antimicrobial and Sedative Hypnotic Activity of Cinnamoyl Ureas
🗓 Year: 2011
🔗 DOI: Not available
📝 Contributors: Vijey Aanandhi, M.; Mishra, P.S.; George, S.; Chaudhary, R.

Moein Masjedi | Pharmacology | Best Researcher Award

Posted on 28/09/202430/09/2024 by Shen Awards

Moein Masjedi | Pharmacology | Best Researcher Award

Moein Masjedi, DarooSazan Sorena Exir Pharmaceutical Company, Iran.

Moein Masjedi is a dedicated researcher in the field of pharmacology, recognized for his innovative contributions to drug development and therapeutic strategies. With a strong academic background and a commitment to advancing scientific knowledge, he has published numerous influential papers that address critical challenges in the field. Awarded the Best Researcher Award for his outstanding research impact, Moein continues to inspire peers and students through his passion for improving health outcomes and enhancing patient care.

Profile:

Education

Moein Masjedi earned his Doctor of Pharmacy degree from Shiraz University of Medical Sciences in Shiraz, Fars, Iran, where he completed his thesis on the drug utilization evaluation of captopril in two coronary care units at Namazi Hospital, achieving a GPA of 15.64 out of 20. He then pursued a Ph.D. in Pharmaceutics at the same institution, focusing on the nose-to-brain delivery of Sumatriptan using chitosan nanoparticles and nanostructured lipid carriers (NLCs), and graduated with a GPA of 17.83 out of 20.

Skills

Moein Masjedi possesses a diverse skill set that enhances his effectiveness as a researcher and collaborator. He excels in strong and collaborative communication, fostering teamwork and idea exchange. His creativity in problem-solving and critical thinking enables him to tackle complex challenges in pharmacology. Demonstrating leadership qualities, he effectively manages projects while prioritizing time management to meet deadlines. Additionally, he is skilled in structural scientific writing and proofreading, ensuring clarity and precision in his research publications. Beyond academia, Moein has a passion for art interpretation and enjoys swimming and yoga, which contribute to his overall well-being and work-life balance.

Areas of Interest:

Moein Masjedi’s research interests focus on innovative drug delivery systems and formulation design. He is particularly passionate about nanoparticulate drug delivery and the optimization of formulations for pulmonary, ocular, topical, and transdermal applications. His work includes designing novel drug delivery systems targeting specific sites such as the pulmonary system, colon, brain, and hair follicles. He explores the use of nanovesicles, lipid, and polymeric nanoparticles for both therapeutic and cosmetic applications. Additionally, Moein is interested in D-optimal optimization of aesthetic formulations and the development of stimuli-responsive or smart polymers for drug delivery. He employs Design of Experiments (DoE) methodologies to optimize formulations and is also engaged in the innovative 3D printing of pharmaceutical dosage forms, aiming to advance the field of pharmaceutics.

Publication Top Notes

Masjedi, M., Izadi, Y., Montahaei, T., Mohammadi, R., Helforoush, M. A., & Rohani Rad, K. (2024). An illustrated review on herbal medicine used for the treatment of female infertility. European Journal of Obstetrics and Gynecology and Reproductive Biology, 0(0).
Dahri, M., Beheshtizadeh, N., Seyedpour, N., Nakhostin-Ansari, A., Aghajani, F., Seyedpour, S., Masjedi, M., Farjadian, F., Maleki, R., & Adibkia, K. (2023). Biomaterial-based delivery platforms for transdermal immunotherapy. Biomedicine & Pharmacotherapy, 165, 115048.
Rezaie, F., Farshbaf, M., Dahri, M., Masjedi, M., Maleki, R., Amini, F., Wirth, J., Moharamzadeh, K., Weber, F. E., & Tayebi, L. (2023). 3D printing of dental prostheses: Current and emerging applications. Journal of Composites Science, 7(2), 80.
Masjedi, M., Montahaei, T., Sharafi, Z., & Jalali, A. (2022). Pulmonary vaccine delivery: An emerging strategy for vaccination and immunotherapy. Journal of Drug Delivery Science and Technology, 103184.
Masjedi, M., & Solhjoo, A. (2022). Does trigonelline help skin tone? Molecular docking studies of trigonelline on the human tyrosinase, formulation, optimization and characterization of an emulgel containing Trigonella foenum‐graecum L. fenugreek standardized hydroalcoholic extract. Journal of Cosmetic Dermatology.
Masjedi, M., & Namazi, S. (2020). Drug utilization evaluation (DUE) of captopril in two coronary care units (CCU) of Namazi Hospital, Shiraz, Iran.
Masjedi, M., & Montahaei, T. (2020). An illustrated review on nonionic surfactant vesicles (niosomes) as an approach in modern drug delivery: Fabrication, characterization, pharmaceutical, and cosmetic applications. Journal of Drug Delivery Science and Technology, 102234.
Masjedi, M., Azadi, A., Heidari, R., & Mohammadi-Samani, S. (2020). Brain targeted delivery of sumatriptan succinate loaded chitosan nanoparticles: Preparation, in vitro characterization, and (neuro-) pharmacokinetic evaluations. Journal of Drug Delivery Science and Technology, 102179.
Ziaei, A., Davoodian, P., Dadvand, H., Safa, O., Hassanipour, S., Omidi, M., Masjedi, M., Mahmoudikia, F., Rafiee, B., & Fathalipour, M. (2020). Evaluation of the efficacy and safety of melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials, 21(1), 1-3.
Masjedi, M., Azadi, A., Heidari, R., & Mohammadi‐Samani, S. (2020). Nose‐to‐brain delivery of sumatriptan‐loaded nanostructured lipid carriers: Preparation, optimization, characterization, and pharmacokinetic evaluation. Journal of Pharmacy and Pharmacology, 72(10), 1341-1351.

Dr. David Haefliger | Pharmacology | Best Researcher Award

Posted on 27/08/202427/08/2024 by Shen Awards

Dr. David Haefliger | Pharmacology | Best Researcher Award

Dr. David Haefliger, CHUV, Switzerland

Dr. David Haefliger is a distinguished expert in pharmacology, recognized for his groundbreaking research and contributions to the field. With a strong background in drug interactions and therapeutic efficacy, Dr. Haefliger’s work has significantly advanced the understanding of pharmacological mechanisms and their clinical applications. His research is widely published in leading journals and has been instrumental in shaping contemporary practices in pharmacology. As a recipient of the Best Researcher Award, Dr. Haefliger continues to drive innovation and excellence in his field, demonstrating an unwavering commitment to advancing medical science and improving patient outcomes.

Profile

Scoopus

Education

Dr. David Haefliger has an extensive educational and professional background in the medical field. He earned his Bachelor’s degree in Medicine in June 2012 and his Master’s degree in Medicine in June 2015, both from the University of Lausanne, Switzerland. In addition to his foundational degrees, he completed the Swiss Board Examination in General Internal Medicine in June 2019, and he is an Advanced Cardiovascular Life Support Provider, certified in October 2016. Most recently, in 2024, Dr. Haefliger obtained a Certificate of Advanced Studies in Clinical Research from the University of Lausanne, further solidifying his expertise and commitment to advancing clinical research.

Proffesional Experience

Since February 2022, Dr. David Haefliger has been working in the Service of Clinical Pharmacology at the Department of Medicine, University Hospital Lausanne, Switzerland. Prior to this role, he served in the Service of Infectious Diseases at the University Hospital Lausanne from November 2019 to October 2021. Dr. Haefliger also gained valuable experience in the Intensive Care Unit at Fribourg Hospital from November 2018 to October 2019. His career began in Internal Medicine at Fribourg Hospital, where he worked from November 2015 to October 2018.

Publication Top Notes

Haefliger D, Chehade H, Livio F, Rodrigues-Veiga V, Diezi L, Marzolini C. Vancomycin Dosing Strategy for the Treatment of Peritonitis in a Child on Automated Peritoneal Dialysis: A First Pediatric Case Report. Semin Dial. 2024.
Dao K, Buettcher M, Golhen K, et al. Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use. J Clin Pharmacol. 2024.
Dao K, Shechtman S, Weber-Schoendorfer C, et al. Use of GLP-1 Receptor Agonists in Early Pregnancy and Reproductive Safety: A Multicentre, Observational, Prospective Cohort Study Based on the Databases of Six Teratology Information Services. BMJ Open. 2024.
Grütter S, Haefliger D, Wuerzner G, Yerly P, Bouchardy J, Rutz T. The Deleterious Consequences of a Nonsteroidal Anti-inflammatory Drug in an Eisenmenger Patient. CJC Pediatr Congenit Heart Dis. 2023.
Haefliger D, Marzolini C, Lamoth F, Pabst T, Buclin T, Livio F. Clinically Relevant Bidirectional Drug-Drug Interaction Between Midostaurin and Voriconazole. Br J Clin Pharmacol. 2023.
Haefliger D, Livio F. Pharmacothérapie – Nouveaux Médicaments et Vaccins Disponibles en 2022 [Pharmacotherapy: New Drugs and Vaccines in 2022]. Rev Med Suisse. 2023.
Desgranges F, Tadini E, Munting A, et al. Post-COVID-19 Syndrome in Outpatients: A Cohort Study. J Gen Intern Med. 2022.
Regina J, Papadimitriou-Olivgeris M, Burger R, et al. Epidemiology, Risk Factors, and Clinical Course of SARS-CoV-2 Infected Patients in a Swiss University Hospital: An Observational Retrospective Study. PLoS One. 2020.
Grandjean T, Haefliger D, Arroyo D, Cook S. Coronary Sinus Reduction for the Treatment of Refractory Angina. Cardiovasc Med. 2018.
Haefliger D, Chuard C. Légionellose [Legionellosis]. Rev Med Suisse. 2017.

Articles with Acknowledgments (as a member of the RegCOVID Study Group):

Galperine T, Choi Y, Pagani JL, et al. Temporal Changes in Fecal Microbiota of Patients Infected with COVID-19: A Longitudinal Cohort. BMC Infect Dis. 2023.
COVID-19 Host Genetics Initiative. Mapping the Human Genetic Architecture of COVID-19. Nature. 2021.
Bibert S, Guex N, Lourenco J, et al. Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients. Front Immunol. 2021.

Vikas Gupta | Pharmacology | Scientific Excellence Achievement Award |

Posted on 10/08/202413/08/2024 by Shen Awards

Dr. Vikas Gupta | Pharmacology | Scientific Excellence Achievement Award |

Assistant Director , Baba Farid University of Health Sciences , India .

Dr. Vikas Gupta is a distinguished pharmaceutical scientist specializing in pharmacognosy and herbal drugs. With over a decade of experience in academia and research, he has made significant contributions to the field of pharmaceutical sciences, particularly in the development and quality control of herbal medicines. His career is marked by a strong academic background, diverse professional roles, innovative research, and numerous awards recognizing his excellence in the field.

Profile

Education

Dr. Gupta holds a Ph.D. in Pharmaceutical Sciences from Baba Farid University of Health Sciences, Faridkot, earned in January 2019. He completed his M. Pharmacy in Pharmacognosy from Punjabi University, Patiala, in 2008 with first-class honors, and his B. Pharmacy from Akal College of Pharmacy & Technical Education, Mastuana Sahib (Sangrur), under Punjab Technical University in 2005, also with first-class honors. His strong academic foundation is further reinforced by his high school education, where he achieved first-class marks from Spring Dales Public School, Sangrur.

Professional Experience

Currently, Dr. Vikas Gupta serves as the Assistant Director and Associate Professor at the University Centre of Excellence in Research, Baba Farid University of Health Sciences, Faridkot, and the University Institute of Pharmaceutical Sciences and Research, Faridkot. His professional journey has included roles as a Production Supervisor at G. M. Remedies Pvt. Ltd., Lecturer at S. D. College of Pharmacy, and Senior Research Fellow at the National Institute of Ayurvedic Pharmaceutical Research. His progression through these roles demonstrates his ability to lead, teach, and conduct advanced research in pharmaceutical sciences.

Research Interests

Dr. Gupta’s primary research interests lie in the field of pharmacognosy, with a particular focus on herbal drugs, quality control, and chromatography. He is passionate about exploring the therapeutic potential of natural products and has dedicated his research to developing and validating herbal medicines that can meet modern healthcare standards. His work is driven by a commitment to improving the safety, efficacy, and quality of herbal drugs, ensuring they are a viable option in the pharmaceutical industry.

Research Skills

Dr. Gupta possesses a wide range of research skills, particularly in the areas of herbal drug technology and chromatography. His expertise includes the development and quality control of herbal drugs, where he employs advanced chromatographic techniques to ensure the purity and potency of these natural medicines. His technical skills are complemented by his experience in supervising and mentoring students in research, where he guides them through complex scientific inquiries and projects.

Awards and Recognition

Dr. Vikas Gupta’s contributions to pharmaceutical sciences have been widely recognized. He has received numerous awards, including the prestigious “Research Excellence Award-2022” from INSC International Publishers and the “Innovative Research Award” for his work on economic plant-based anti-anxiety drugs. He has also been honored with fellowships from the UPYA Foundation of Multidisciplinary Sciences, the Indian Association of Pharmaceutical Scientists and Technologists, and the Scholars Academic and Scientific Society. His recognition extends internationally, with awards such as the Bentham Ambassador by Bentham Science Publishers and the Bharat Gaurav Puraskar for his contributions to the field.

Conclusion

Dr. Vikas Gupta’s qualifications, extensive experience, and numerous recognitions make him a compelling candidate for the Scientific Excellence Achievement Award. His contributions to pharmacognosy, herbal drugs, and pharmaceutical sciences are significant and align well with the criteria for such an award.

Publications Top Notes

2024:

Topic: “Recommendations of Apex Health Bodies Remain Localized: Not in Conformity with International Implementation Policy for Urological Disorders”

Journal: The Lancet Regional Health – Southeast Asia

2024:

Topic: “Populations Using Traditional Home Remedy at Low Risk for COVID-19 Infection”

Journal: Current Traditional Medicine

2023:

Topic: “Future and Research Opportunity in Pharmaceutical Development and Quality Measures”

Book Chapter: Pharmaceuticals in Aquatic Environments: Remediation Technologies and Future Challenges

2023:

Topic: “Functional Finishing of Textile Materials Using Silver-Based Functionalized Nanoparticles: Health Perspectives”

Book Chapter: Antiviral and Antimicrobial Coatings Based on Functionalized Nanomaterials: Design, Applications, and Devices

2023:

Topic: “Bioinformatics Paradigms in Drug Discovery and Drug Development”

Journal: Current Topics in Medicinal Chemistry

2022:

Topic: “Grain Weight Predictors in Wheat and the Prospects of Their Utilization in Different Production Environments”

Journal: Cereal Research Communications

2022:

Topic: “Fast Track Development of Fisetin and Naringenin Based Economic Anti-Anxiety Drug Using Docking Tools”

Journal: Asian Journal of Psychiatry

2022:

Topic: “Ashtawarga: The Wonder Medicinal Herbs of Nature”

Book Chapter: Herbs, Spices and Their Roles in Nutraceuticals and Functional Foods

2022:

Topic: “Future Prospective of Nutraceutical and Functional Food with Herbs and Spices”

Book Chapter: Herbs, Spices and Their Roles in Nutraceuticals and Functional Foods

2022:

Topic: “Preface”

Editorial: New Horizons in Wheat and Barley Research: Global Trends, Breeding and Quality Enhancement